Results 271 to 280 of about 3,908,577 (301)

Biomimetic Scaffold‐Based 3D Models for Decoding Cancer Biology and Advancing Therapy

Advanced Science, EarlyView.
A timeline of the research history of 3D biomimetic scaffold materials and platforms. With advances in biomimetic materials and 3D scaffold technologies, their functional scope has expanded from mimicking basic physical and biochemical properties to increasingly replicating complex pathophysiological processes.
Haitao Zhao, Yuechen Han, Jie Li, Peng Luo, Lin Qi, Zhiwei Xia, Xiaosong Li, Quan Cheng, Chenshen Huang, Wantao Wu, Hao Zhang   +10 more
wiley   +1 more source

Metabolite-driven dysfunction of intratumoral tertiary lymphoid structures: single-cell and spatial omics perspectives on cancer immune escape. [PDF]

Front Immunol
Wang Y, Li Y, Wei S, Ding S.
europepmc   +1 more source

Adaptive Advantage of the Emerging Seasonal Influenza A (H3N2) Subclade K: Enhanced Receptor Binding Capacity and Immune Escape Potential. [PDF]

MedComm (2020)
Zhang L, Zhao T, Pan X, Feng Z, Zhang D, Wang Q, Yang P.   +6 more
europepmc   +1 more source

The Tryptophan Paradox: From Microbiome-Mediated Homeostasis to Tumor-Driven Immune Escape. [PDF]

Int J Mol Sci
Cho A, Wu C, Theodoropoulos G, Nagarajan M, Murphy AM, Heller KF, Savaraj N, Lampidis TJ, Wangpaichitr M.   +8 more
europepmc   +1 more source

PSIP1 Orchestrates Immune Escape in Osteosarcoma: Insights From Single-Cell Analysis and Implications for Immunotherapy Resistance. [PDF]

Int J Genomics
Liu S, Yan H, Ku W, Liu G.
europepmc   +1 more source

Rewiring immunity: Midkine's emerging role in cancer immune escape and drug resistance. [PDF]

iScience
Saikia M, Prem S, Kapoor V.
europepmc   +1 more source

Targeting molecular residual disease and immune escape in colorectal cancer recurrence: biomarker-guided immunotherapy and cell therapies. [PDF]

Front Med (Lausanne)
Shan Y, Zhang X, Liu J, Hu B, Yang L, Wang H, Li J, Jiang Z, Gong G.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CD155 and its receptors in cancer immune escape and immunotherapy.

Cancer Letters, 2023
In recent years, there have been multiple breakthroughs in cancer immunotherapy, with immune checkpoint inhibitors becoming the most promising treatment strategy. However, available drugs are not always effective.
R. Zhou, Shi-Yi Chen, Qiwen Wu, Ling-Yun Liu, Yian Wang, Yongzhen Mo, Z. Zeng, Xuyu Zu, W. Xiong, Fuyan Wang   +9 more
semanticscholar   +1 more source

H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer.

Cancer Research
The recently discovered epigenetic modification lysine lactylation (Kla) contributes to tumor development and progression in several types of cancer.
Cai-Hong Zhang, Lijie Zhou, Ming-Yuan Zhang, Yue Du, Cai Li, Huijun Ren, Lu Zheng   +6 more
semanticscholar   +1 more source

The immune escape mechanism of nasopharyngeal carcinoma

The FASEB Journal, 2023
Tumor cells are known for being able to evade immune system surveillance, a hallmark of malignancy. Complicated immune escape mechanisms in the tumor microenvironment (TME) provide favorable conditions for tumor invasion, metastasis, treatment resistance,
Xiao-Xu Li, Yi Guo, Minmin Xiao, Wenling Zhang   +3 more
semanticscholar   +1 more source